secwatch.observer — SEC 8-K summary
======================================

Issuer:     GOLDENWELL BIOTECH, INC. (GWLL)
CIK:        0001800373
Form:       8-K
Filed at:   2021-09-09T23:59:59+00:00
Accession:  0001477932-21-006166
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Goldenwell Biotech dismisses auditor Gillespie & Associates, engages BF Borgers
-------------------------------------------------------------------------------

- Dismissed Michael Gillespie & Associates on Sept 8, 2021, effective immediately.
- Engaged BF Borgers CPA PC as new independent auditor on the same date.
- Former auditor's reports included a going concern uncertainty; no disagreements on accounting principles.
- No reportable events under Item 304(a)(1)(v) of Regulation S-K during prior years.
- Former auditor's response letter filed as Exhibit 16.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1800373/000147793221006166/0001477932-21-006166-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1800373/000147793221006166/gdwl_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-21-006166

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer